Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Neurology
|
September 17, 1999
Quantitative assessment of motor fatigue and strength in MS
S R Schwid, C A Thornton, S Pandya, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 25, 2005
Serum ovalbumin-specific immunoglobulin G responses during pregnancy reflect maternal intake of dietary egg and relate to the development of allergy in early infancy
G H S Vance, K E C Grimshaw, R Briggs, et al.
Muscle & Nerve
|
May 10, 2005
Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1
E L Logigian, C L Blood, N Dilek, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
October 22, 2005
Exposure of the fetus and infant to hens' egg ovalbumin via the placenta and breast milk in relation to maternal intake of dietary egg
G H S Vance, S A Lewis, K E C Grimshaw, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease
J N Gordon, J D Prothero, C A Thornton, et al.
Neurology
|
April 14, 2004
Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1
E L Logigian, R T Moxley, C L Blood, et al.
Clinical and Experimental Immunology
|
March 16, 2017
Human gestation-associated tissues express functional cytosolic nucleic acid sensing pattern recognition receptors
A H Bryant, G E Menzies, L M Scott, et al.
Neurology
|
January 16, 2008
The hypocretin neurotransmission system in myotonic dystrophy type 1
E Ciafaloni, E Mignot, V Sansone, et al.
Human Molecular Genetics
|
October 9, 2001
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2
A Mankodi, C R Urbinati, Q P Yuan, et al.
Neurology
|
May 5, 2010
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
E L Logigian, W B Martens, R T Moxley, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Neurology
|
September 17, 1999
Quantitative assessment of motor fatigue and strength in MS
S R Schwid, C A Thornton, S Pandya, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 25, 2005
Serum ovalbumin-specific immunoglobulin G responses during pregnancy reflect maternal intake of dietary egg and relate to the development of allergy in early infancy
G H S Vance, K E C Grimshaw, R Briggs, et al.
Muscle & Nerve
|
May 10, 2005
Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1
E L Logigian, C L Blood, N Dilek, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
October 22, 2005
Exposure of the fetus and infant to hens' egg ovalbumin via the placenta and breast milk in relation to maternal intake of dietary egg
G H S Vance, S A Lewis, K E C Grimshaw, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease
J N Gordon, J D Prothero, C A Thornton, et al.
Neurology
|
April 14, 2004
Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1
E L Logigian, R T Moxley, C L Blood, et al.
Clinical and Experimental Immunology
|
March 16, 2017
Human gestation-associated tissues express functional cytosolic nucleic acid sensing pattern recognition receptors
A H Bryant, G E Menzies, L M Scott, et al.
Neurology
|
January 16, 2008
The hypocretin neurotransmission system in myotonic dystrophy type 1
E Ciafaloni, E Mignot, V Sansone, et al.
Human Molecular Genetics
|
October 9, 2001
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2
A Mankodi, C R Urbinati, Q P Yuan, et al.
Neurology
|
May 5, 2010
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
E L Logigian, W B Martens, R T Moxley, et al.
Page
of 7